Baird Starts CVS Health (CVS) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $92.58 +2.42%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Join SI Premium – FREE
Baird analyst Michael Ha initiates coverage on CVS Health (NYSE: CVS) with a Neutral rating and a price target of $61.00.
For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.
Shares of CVS Health closed at $53.63 yesterday.
You May Also Be Interested In
- CVS Health partners with The Midlife Collective on women's health study
- Citi Resumes Johnson Matthey Plc. (JMAT:LN) (JMPLY) at Buy
- William Blair Starts Kardigan Inc (KARD) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
